Filippo Maria Verardi

Filippo Maria Verardi

Auto-generated profile, based on publicly available information

Filippo Maria Verardi

Cardiology Unit Azienda Ospedaliero‐Universitaria di Ferrara Ferrara Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RPRita Pavasini
Rita Pavasini
GFGioele Fabbri
Gioele Fabbri
FMFederico Marchini
Federico Marchini
NBNicola Bianchi
Nicola Bianchi
MDMaria Angela Deserio
Maria Angela Deserio
Rosario CultreraRosario Cultrera
Rosario Cultrera
This study compiles data to determine if procalcitonin (PCT) values may predict both the risk of bacterial infection and potentially negative long-term outcomes in patients with acute coronary syndromes (ACS). All patients with a diagnosis of ACS that had PCT levels assessed during the first 24 h of hospitalization were enrolled in this study. The primary outcome was to detect the presence of bacterial infection defined as the occurrence of fever and at least one positive blood or urinary culture with clinical signs of infection. The secondary outcome was to monitor the occurrence after 1 year of the composite outcome of all-cause mortality, stroke and myocardial infarction. Overall, 569 patients were enrolled (mean age 69.37 ± 14 years, 30% females). Of these, 44 (8%) met the criteria for bacterial infection. After multivariate analysis, PCT and SBP were found to be independent predictors of bacterial infections (OR for PCT above the cut-off 2.67, 95% CI 1.09–6.53, p = 0.032 and OR for SBP 0.98, 95% CI 0.97–0.99, p = 0.043). After 1 year, the composite outcome of all-cause death, MI and stroke occurred in 104 patients (18%). PCT was not found to be an independent predictor of these outcomes. In conclusion, when assessing ACS, we found that testing for PCT levels during hospital admissions procedures was a good predictor of bacterial infections but not of all-cause mortality, stroke, or myocardial infarction. Clinicaltrial.org identifier: NCT02438085.

10 January 2021 in Hearts
Verified
Journal Article
Open access
PDF file
Michele MalagùMichele Malagù
Michele Malagù
VFVitali Francesco
Vitali Francesco
URUgo Rizzo
Ugo Rizzo
ABAlessandro Brieda
Alessandro Brieda
OZOttavio Zucchetti
Ottavio Zucchetti
Matteo BertiniMatteo Bertini
Matteo Bertini
Background: Heart rate variability (HRV) is widely used in professional soccer players as a tool to assess individual response to training load. Different devices and methods are available for HRV assessment. The relationship between HRV and competitive soccer matches performance is not documented. Methods: We monitored HRV in professional soccer players throughout a game season. Measurements were performed with a portable lightweight device in weekly 5 min sessions from which we obtained the value of the square root of the mean squared differences of successive beat-to-beat intervals (rMSSD). Game parameters of run and velocity were collected. Results: Twenty-seven players were monitored with a total of 121 observations. The rMSSD significantly related with the total distance covered (p = 0.036) and with the distance covered running at >15 km/h (p = 0.039) during soccer games. Conclusions: HRV was associated with competition performance in professional soccer players.

1 July 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
ASAntonella Scala
Antonella Scala
AEAndrea Erriquez
Andrea Erriquez
MCMarta Cocco
Marta Cocco
FVFilippo Maria Verardi
Filippo Maria Verardi
SCSerena Caglioni
Serena Caglioni
SBSimone Biscaglia
Simone Biscaglia

Verified
Journal Article
Open access
PDF file
Matteo BertiniMatteo Bertini
Matteo Bertini
EDEmanuele D'Aniello
Emanuele D'Aniello
ACAlberto Cereda
Alberto Cereda
MTMarco Toselli
Marco Toselli
FVFilippo Maria Verardi
Filippo Maria Verardi
FGFrancesco Giannini
Francesco Giannini
Aims. Several studies have unveiled the great heterogeneity of COVID-19 pneumonia. Identification of the “vascular phenotype” (involving both pulmonary parenchyma and its circulation) has prognostic significance. Our aim was to explore the combined role of chest computed tomography (CT) scan and electrocardiogram (ECG) at hospital admission in predicting short-term prognosis and to draw pathophysiological insights. Methods and Results. We analyzed the chest CT scan and ECG performed at admission in 151 consecutive COVID-19 patients admitted between 20 March and 4 April 2020. All-cause mortality within 30 days was the primary endpoint. Median age was 71 years (IQR: 62–76). Severe pneumonia was present in 25 (17%) patients, and 121 (80%) had abnormal ECG. During a median follow-up of 7 days (IQR: 4–13), 54 (36%) patients died. Deceased patients had more severe pneumonia than survivors did (80% vs. 64%, p = 0.044). ECG in deceased patients showed more frequently atrial fibrillation/flutter (17% vs. 6%, p = 0.039) and acute right ventricular (RV) strain (35% vs. 10%, p < 0.001), suggesting the “vascular phenotype”. ECG signs of acute RV strain (HR 2.46, 95% CIs 1.36–4.45, p = 0.0028) were independently associated with all-cause mortality in multivariable analysis, and in the likelihood ratio test, showed incremental prognostic value over chest CT scan, age, and C-reactive protein. Conclusions. Combining chest CT scan and ECG data improves risk stratification in COVID-19 pneumonia by identifying a distinctive phenotype with both parenchymal and vascular damage of the lung. Patients with severe pneumonia at chest CT scan plus ECG signs of acute RV strain have an extremely poor short-term prognosis.

8 September 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASAntonella Scala
Antonella Scala
AEAndrea Erriquez
Andrea Erriquez
FVFilippo Maria Verardi
Filippo Maria Verardi
AMAndrea Marrone
Andrea Marrone
ESEnnio Scollo
Ennio Scollo
SBSimone Biscaglia
Simone Biscaglia
The present study investigates the prognostic value of the Syntax Score II 2020 corrected for flow-limiting lesions and its ability to better address treatment by benefit prediction among patients with left main or multivessel disease. We analyzed 1274 patients from the HALE-BOPP cohort and integrated the Syntax Score II 2020 with the result of the fractional flow reserve (FFR) evaluation. Absolute risk difference (ARD) between surgical and percutaneous revascularization was calculated for anatomic and functional Syntax Score II 2020 predicted mortality. The ARD allowed to stratify the population into two large categories: “coronary artery bypass graft (CABG) better” with ARD ≥ 4.5% and “CABG–percutaneous coronary intervention (PCI) equipoise” with ARD < 4.5%. The mean global anatomical Syntax Score was 15.5 ± 9.2, whereas the functional one was 9.5 ± 10 (p < 0.01). Using the anatomic Syntax Score II 2020, 881 patients had a CABG-PCI equipoise. This number increased to 1041 after considering only flow-limiting lesions by FFR (p < 0.001); therefore, 40% of CABG better patients were reclassified within the CABG-PCI equipoise category. Kaplan–Maier curves showed similar actual survival rates for patients originally with CABG-PCI equipoise and those reclassified, in both cases higher than those from CABG better patients (p < 0.01). The integration between Syntax Score II 2020 and physiology is feasible, and merging clinical, anatomic and functional data allows for better risk prediction and therapeutic guidance.

1 November 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
ASAlberto Sarti
Alberto Sarti
AEAndrea Erriquez
Andrea Erriquez
BPBeatrice Dal Passo
Beatrice Dal Passo
GCGianni Casella
Gianni Casella
VGVincenzo Guiducci
Vincenzo Guiducci
SBSimone Biscaglia
Simone Biscaglia
BACKGROUND: The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) showed the superiority of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease. Whether this result applies equally to patients at higher risk of ischemic events due to nonculprit lesion complexity is unclear. METHODS: Overall, 1445 patients were randomized to culprit-only or complete revascularization. In this prespecified analysis, patients were divided into those with or without at least 1 complex nonculprit lesion. A nonculprit lesion was defined as complex if it met any of the following criteria: angiographic heavy calcification, ostial lesion, true bifurcation lesion involving side-branches >2.5 mm, in-stent restenosis, or long-lesions (estimated stent length >28 mm). The primary outcome comprised a composite of death, MI, stroke, or revascularization at 3 years. The key secondary outcome was a composite of cardiovascular death or MI. The safety outcome included a composite of contrast-associated acute kidney injury, stroke, and Bleeding Academic Research Consortium 3 to 5. RESULTS: Overall, 641 patients (44%, complex subgroup) had at least 1 complex nonculprit lesion, whereas 804 patients (56%, noncomplex subgroup) did not. After adjustment for potential confounders, patients in the complex subgroup were at higher risk of 3-year cardiovascular death or MI (hazard risk [HR], 1.32 [95% CI, 1.01–1.74]), MI (HR, 2.33 [95% CI, 1.44–3.78]) and ischemia-driven coronary revascularization (HR, 2.28 [95% CI, 1.46–3.56]). Complete revascularization reduced the primary outcome in both the complex (HR, 0.75 [95% CI, 0.56–0.99]) and noncomplex (HR, 0.71 [95% CI, 0.53–0.95]) subgroups, with no significant interaction ( P for interaction=0.625). Similarly, no evidence of heterogeneity related to nonculprit lesion complexity was observed for either key secondary or safety end points. CONCLUSIONS: In older patients with MI and multivessel disease, physiology-guided complete revascularization reduced ischemic events, regardless of the complexity of nonculprit lesions. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03772743.